|
Lemaitre Vascular, Inc. (LMAT) Évaluation DCF
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
LeMaitre Vascular, Inc. (LMAT) Bundle
Simplifier Lemaitre Vascular, Inc. (LMAT) Valation avec cette calculatrice DCF personnalisable! Doté de Real Lemaitre Vascular, Inc. (LMAT) Financials and Rajustement des entrées de prévision, vous pouvez tester les scénarios et découvrir la juste valeur de Lemaitre Vascular, Inc. (LMAT) en minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 129.4 | 154.4 | 161.7 | 193.5 | 219.9 | 251.4 | 287.5 | 328.7 | 375.8 | 429.8 |
| Revenue Growth, % | 0 | 19.37 | 4.68 | 19.69 | 13.63 | 14.34 | 14.34 | 14.34 | 14.34 | 14.34 |
| EBITDA | 36.9 | 46.0 | 36.9 | 49.0 | 52.3 | 65.5 | 74.9 | 85.6 | 97.9 | 111.9 |
| EBITDA, % | 28.52 | 29.78 | 22.84 | 25.32 | 23.77 | 26.04 | 26.04 | 26.04 | 26.04 | 26.04 |
| Depreciation | 8.2 | 9.5 | 9.4 | 9.5 | .0 | 11.7 | 13.4 | 15.3 | 17.5 | 20.0 |
| Depreciation, % | 6.36 | 6.14 | 5.84 | 4.92 | 0 | 4.65 | 4.65 | 4.65 | 4.65 | 4.65 |
| EBIT | 28.7 | 36.5 | 27.5 | 39.5 | 52.3 | 53.8 | 61.5 | 70.3 | 80.4 | 91.9 |
| EBIT, % | 22.16 | 23.64 | 17.01 | 20.4 | 23.77 | 21.39 | 21.39 | 21.39 | 21.39 | 21.39 |
| Total Cash | 27.0 | 70.0 | 82.7 | 105.1 | 299.7 | 136.6 | 156.2 | 178.6 | 204.2 | 233.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 19.6 | 19.6 | 22.0 | 25.1 | 30.1 | 34.2 | 39.1 | 44.8 | 51.2 | 58.5 |
| Account Receivables, % | 15.11 | 12.71 | 13.63 | 12.95 | 13.67 | 13.62 | 13.62 | 13.62 | 13.62 | 13.62 |
| Inventories | 45.1 | 46.1 | 50.3 | 52.3 | 64.9 | 76.6 | 87.6 | 100.2 | 114.6 | 131.0 |
| Inventories, % | 34.87 | 29.86 | 31.1 | 27.05 | 29.53 | 30.48 | 30.48 | 30.48 | 30.48 | 30.48 |
| Accounts Payable | 2.4 | 2.3 | 2.9 | 3.7 | 1.8 | 4.0 | 4.5 | 5.2 | 5.9 | 6.8 |
| Accounts Payable, % | 1.85 | 1.52 | 1.8 | 1.93 | 0.80095 | 1.58 | 1.58 | 1.58 | 1.58 | 1.58 |
| Capital Expenditure | -3.0 | -4.9 | -3.2 | -7.3 | -7.0 | -7.2 | -8.3 | -9.5 | -10.8 | -12.4 |
| Capital Expenditure, % | -2.31 | -3.16 | -2 | -3.75 | -3.17 | -2.88 | -2.88 | -2.88 | -2.88 | -2.88 |
| Tax Rate, % | 22.57 | 22.57 | 22.57 | 22.57 | 22.57 | 22.57 | 22.57 | 22.57 | 22.57 | 22.57 |
| EBITAT | 22.2 | 28.6 | 20.6 | 30.1 | 40.5 | 41.4 | 47.3 | 54.1 | 61.9 | 70.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -34.8 | 32.1 | 20.8 | 28.1 | 13.9 | 32.2 | 37.1 | 42.4 | 48.5 | 55.5 |
| WACC, % | 8.12 | 8.13 | 8.11 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 168.1 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 58 | |||||||||
| Terminal Value | 1,400 | |||||||||
| Present Terminal Value | 947 | |||||||||
| Enterprise Value | 1,115 | |||||||||
| Net Debt | 160 | |||||||||
| Equity Value | 955 | |||||||||
| Diluted Shares Outstanding, MM | 23 | |||||||||
| Equity Value Per Share | 41.94 |
What You Will Receive
- Genuine LeMaitre Data: Preloaded financial metrics – encompassing revenue to EBIT – derived from actual and projected statistics.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on LeMaitre's fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth forecasting.
- Efficient and Precise: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive Financial Data: LeMaitre Vascular’s historical financial statements and pre-filled forecasts.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Observe LeMaitre Vascular’s intrinsic value recalculating instantly.
- Intuitive Visualizations: Dashboard charts present valuation results and essential metrics clearly.
- Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.
How It Works
- Download: Obtain the pre-built Excel file containing LeMaitre Vascular, Inc.'s (LMAT) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and instantly compare the results.
- Make Decisions: Leverage the valuation insights to inform your investment approach.
Why Choose This Calculator for LeMaitre Vascular, Inc. (LMAT)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your financial analysis needs.
- Real-Time Valuation: Observe immediate updates to LeMaitre’s valuation as you modify inputs.
- Preloaded Data: Comes with LeMaitre’s actual financial figures for swift evaluations.
- Relied Upon by Experts: Trusted by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for analyzing investments in the medical device sector.
- Corporate Finance Teams: Evaluate financial scenarios to support strategic decision-making within the organization.
- Consultants and Advisors: Deliver precise valuation insights for LeMaitre Vascular, Inc. (LMAT) to clients in the healthcare industry.
- Students and Educators: Utilize real-world data to enhance learning and teaching of financial modeling techniques.
- Medical Device Enthusiasts: Gain insights into how companies like LeMaitre Vascular, Inc. (LMAT) are valued in the healthcare market.
What the Template Contains
- Preloaded LMAT Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.